News & Events

News, initiatives, and events highlighting our daily commitment to research, prevention, and the sharing of scientific results

Le nostre eccellenze: Il Dottor. Alessandro Rizzo vincitore del prestigioso ESMO Merit Award 2026
Celebrating Excellence: Dr. Alessandro Rizzo, Recipient of the Prestigious ESMO Merit Award 2026
The prestigious award was presented during the ESMO Targeted Anticancer Therapies (TAT) 2026 congress in Paris. Read more...
Una nuova frontiera nell’uso dell’immunoterapia e delle terapie a bersaglio al posto della chemioterapia nelle fasi perioperatorie in pazienti con neoplasie vescicali
A new frontier in the use of immunotherapy and targeted therapies instead of chemotherapy in the perioperative setting for patients with bladder cancer
The study published by Professor Andrea Necchi in the international journal The Lancet Oncology, titled “Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer... Read more...
Congresso 6-7 Maggio promosso dall’ARON Research Foundation ETS
ARON Research Foundation ETS Congress | May 6-7
On May 6th and 7th, the II International Meeting of the ARON Group, promoted by the ARON Research Foundation ETS, will take place in the classrooms of Asilo Ricci in... Read more...
Microplastiche in pazienti con tumori prostatici
Microplastics in patients with prostate cancer
A recent study conducted at New York University explored the potential role of microplastics in the development of prostate cancer, the most common cancer among men in the United States,... Read more...